R. Oberneder

2.7k total citations
59 papers, 2.1k citations indexed

About

R. Oberneder is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, R. Oberneder has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in R. Oberneder's work include Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Bladder and Urothelial Cancer Treatments (14 papers). R. Oberneder is often cited by papers focused on Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Bladder and Urothelial Cancer Treatments (14 papers). R. Oberneder collaborates with scholars based in Germany, United States and Austria. R. Oberneder's co-authors include A. Hofstetter, G. Riethmüller, M. Kriegmair, Klaus Pantel, Rainer Riesenberg, Günter Schlimok, M. W. Köllermann, Alfred Zippelius, Heike Pohla and Christian G. Stief and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

R. Oberneder

59 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Oberneder Germany 21 877 788 561 449 423 59 2.1k
Heribert Juergens Germany 26 1.1k 1.2× 1.6k 2.0× 1.0k 1.9× 593 1.3× 366 0.9× 60 3.3k
Alexander J. Chou United States 25 726 0.8× 1.1k 1.4× 931 1.7× 503 1.1× 241 0.6× 61 2.4k
Michael S. Isakoff United States 17 583 0.7× 718 0.9× 948 1.7× 530 1.2× 378 0.9× 35 2.2k
Panagiota Economopoulou Greece 26 1.4k 1.6× 597 0.8× 891 1.6× 628 1.4× 277 0.7× 105 2.7k
Jinming Yu China 19 1.2k 1.4× 671 0.9× 579 1.0× 456 1.0× 285 0.7× 66 2.3k
Silke Flege Germany 14 761 0.9× 2.0k 2.5× 757 1.3× 492 1.1× 633 1.5× 22 2.9k
Franco Di Filippo Italy 25 847 1.0× 306 0.4× 477 0.9× 266 0.6× 412 1.0× 80 1.9k
Pascale Mariani France 29 1.3k 1.4× 444 0.6× 731 1.3× 602 1.3× 604 1.4× 108 2.8k
Jung Shin Lee South Korea 23 554 0.6× 533 0.7× 590 1.1× 210 0.5× 199 0.5× 86 1.8k
Nicholas Willumsen Denmark 26 811 0.9× 330 0.4× 609 1.1× 455 1.0× 178 0.4× 82 2.0k

Countries citing papers authored by R. Oberneder

Since Specialization
Citations

This map shows the geographic impact of R. Oberneder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Oberneder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Oberneder more than expected).

Fields of papers citing papers by R. Oberneder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Oberneder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Oberneder. The network helps show where R. Oberneder may publish in the future.

Co-authorship network of co-authors of R. Oberneder

This figure shows the co-authorship network connecting the top 25 collaborators of R. Oberneder. A scholar is included among the top collaborators of R. Oberneder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Oberneder. R. Oberneder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antoniewicz, Artur A., Frederik Wessels, M. Lenhart, et al.. (2024). 2010P Trifunctional anti-EpCAM/CD3 bsAb catumaxomab intravesically for high and intermediate risk non muscle invasive bladder cancer (HMR-NMIBC): Interim analysis of a phase I study. Annals of Oncology. 35. S1160–S1160. 3 indexed citations
2.
Vogelhuber, Martin, Susan Feyerabend, Arnulf Stenzl, et al.. (2014). Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. Cancer Microenvironment. 8(1). 33–41. 12 indexed citations
3.
Siebels, Michael, K. Rohrmann, R. Oberneder, et al.. (2010). A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World Journal of Urology. 29(1). 121–126. 85 indexed citations
4.
Engel, Jutta, Patrick J. Bastian, C. Chaussy, et al.. (2010). Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer. European Urology. 57(5). 754–761. 178 indexed citations
5.
6.
Siemer, Stefan, Sven Lahme, S. Machtens, et al.. (2007). Efficacy and Safety of TachoSil ® as Haemostatic Treatment versus Standard Suturing in Kidney Tumour Resection: A Randomised Prospective Study. European Urology. 52(4). 1156–1163. 121 indexed citations
7.
Hofmann, Thomas, Alexander Büchner, A. Hofstetter, et al.. (2007). Prognostic relevance of disseminated tumour cells in bone marrow of patients with transitional cell carcinoma. European Journal of Cancer. 43(18). 2678–2684. 4 indexed citations
8.
Büchner, Alexander, Rainer Riesenberg, Ina Kötter, et al.. (2006). Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma. Cancer. 106(7). 1514–1520. 10 indexed citations
9.
Piltz, Stefan, et al.. (2003). Lungenmetastasenchirurgie beim Nierenzellkarzinom. Der Urologe. 42(9). 1230–1237. 7 indexed citations
10.
Oberneder, R., et al.. (2003). Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder: impact on function. International Urology and Nephrology. 35(2). 175–179. 5 indexed citations
11.
Kavoussi, Louis R., Dan Stoianovici, C. Adam, et al.. (2002). Telerobotische Chirurgie zwischen Baltimore und München. Der Urologe. 41(5). 489–492. 15 indexed citations
12.
Siebels, Michael, R. Oberneder, Alexander Büchner, et al.. (2002). Ambulante Radiochirurgie bei zerebral metastasiertem Nierenzellkarzinom Fünfjahresergebnisse von 58 Patienten. Der Urologe. 41(5). 482–488. 9 indexed citations
13.
Schaffer, Moshe, P.M. Schaffer, Birgit Ertl‐Wagner, et al.. (2002). Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer—a report of two cases. Photochemical & Photobiological Sciences. 1(9). 686–689. 16 indexed citations
14.
Corvin, Stefan, R. Oberneder, C. Adam, et al.. (2001). Use of hydro-jet cutting for laparoscopic partial nephrectomy in a porcine model. Urology. 58(6). 1070–1073. 23 indexed citations
15.
Zaak, Dirk, M. Kriegmair, Herbert Stepp, et al.. (2001). Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology. 57(4). 690–694. 154 indexed citations
16.
Oberneder, R., M. Kriegmair, Michael Staehler, & A. Hofstetter. (1997). Immuntherapie des metastasierten NierenzellkarzinomsIst der klinische Einsatz in Anbetracht der Ergebnisse, Nebenwirkungen und Kosten gerechtfertigt?. Der Urologe. 36(2). 130–137. 1 indexed citations
17.
Kriegmair, M., R. Oberneder, & A. Hofstetter. (1995). Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma. Urology. 45(5). 758–762. 52 indexed citations
18.
Pantel, Klaus, Achim Dickmanns, Alfred Zippelius, et al.. (1995). Establishment of Micrometastatic Carcinoma Cell Lines: a Novel Source of Tumor Cell Vaccines. JNCI Journal of the National Cancer Institute. 87(15). 1162–1168. 95 indexed citations
19.
Oberneder, R., Rainer Riesenberg, M. Kriegmair, et al.. (1994). Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urological Research. 22(1). 3–8. 36 indexed citations
20.
Oberneder, R., R Friedrich, K.‐P. Dieckmann, et al.. (1990). Overview of the West German Urological Multicenter Study Traumatology. World Journal of Urology. 7(4). 227–234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heribert Juergens Breakdown of academic impact, for papers by Alexander J. Chou Breakdown of academic impact, for papers by Michael S. Isakoff Breakdown of academic impact, for papers by Panagiota Economopoulou Breakdown of academic impact, for papers by Jinming Yu Breakdown of academic impact, for papers by Silke Flege Breakdown of academic impact, for papers by Franco Di Filippo Breakdown of academic impact, for papers by Pascale Mariani Breakdown of academic impact, for papers by Jung Shin Lee Breakdown of academic impact, for papers by Nicholas Willumsen
Rankless by CCL
2026